1-(5-chloro-2-methoxybenzyl)-N-(4-methoxyphenyl)-5-(4-methyl-2-pivalamidothiazol-5-yl)-1H-pyrazole-3-carboxamide

ID: ALA1098499

PubChem CID: 46888150

Max Phase: Preclinical

Molecular Formula: C28H30ClN5O4S

Molecular Weight: 568.10

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(NC(=O)c2cc(-c3sc(NC(=O)C(C)(C)C)nc3C)n(Cc3cc(Cl)ccc3OC)n2)cc1

Standard InChI:  InChI=1S/C28H30ClN5O4S/c1-16-24(39-27(30-16)32-26(36)28(2,3)4)22-14-21(25(35)31-19-8-10-20(37-5)11-9-19)33-34(22)15-17-13-18(29)7-12-23(17)38-6/h7-14H,15H2,1-6H3,(H,31,35)(H,30,32,36)

Standard InChI Key:  XFVIVPVOVWFIKG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 42  0  0  0  0  0  0  0  0999 V2000
    9.4209  -18.5602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2190  -18.3514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2690  -17.5278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9781  -17.8655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9641  -17.0835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6964  -17.4634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9269  -16.2593    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1192  -19.3264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3208  -19.5342    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.2718  -20.3578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0399  -20.6589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5635  -20.0215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3871  -20.0705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5767  -20.8021    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6139  -21.6263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9188  -22.0706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3463  -22.0061    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1864  -21.6908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9561  -22.8948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2091  -22.4941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1545  -17.8179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7839  -17.0808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6221  -15.8150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2395  -16.3936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8696  -15.6571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0451  -15.6089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5919  -16.3034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9643  -17.0372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3513  -16.1978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0460  -15.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0092  -14.9291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2718  -14.5497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5802  -14.9955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7037  -14.4839    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4366  -14.8628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0630  -16.4431    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4319  -17.1811    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5176  -15.7547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7681  -16.2587    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 37  4  1  0
 16 19  1  0
  4  1  1  0
 16 20  1  0
  4 21  1  0
  3  5  1  0
 21 22  1  0
  9 10  1  0
  7 23  1  0
 10 11  2  0
 22 24  2  0
 11 12  1  0
 24 25  1  0
 12  8  2  0
 25 26  2  0
  1  8  1  0
 26 27  1  0
  1  2  2  0
 27 28  2  0
 28 22  1  0
 12 13  1  0
 23 29  2  0
  5  6  2  0
 29 30  1  0
 10 14  1  0
 30 31  2  0
  2  3  1  0
 31 32  1  0
 14 15  1  0
 32 33  2  0
 33 23  1  0
  5  7  1  0
 31 34  1  0
 15 16  1  0
 34 35  1  0
  8  9  1  0
 24 36  1  0
 15 17  2  0
  3 37  2  0
 36 38  1  0
 16 18  1  0
 27 39  1  0
M  END

Associated Targets(Human)

CFTR Tclin Cystic fibrosis transmembrane conductance regulator (2075 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 568.10Molecular Weight (Monoisotopic): 567.1707AlogP: 6.27#Rotatable Bonds: 8
Polar Surface Area: 107.37Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.91CX Basic pKa: CX LogP: 5.97CX LogD: 5.86
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.26Np Likeness Score: -1.83

References

1. Ye L, Knapp JM, Sangwung P, Fettinger JC, Verkman AS, Kurth MJ..  (2010)  Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles.,  53  (9): [PMID:20373765] [10.1021/jm100235h]

Source